Literature DB >> 25330756

Neurogenic differentiation from adipose-derived stem cells and application for autologous transplantation in spinal cord injury.

Yong Zhao1, Hui Jiang, Xin-wei Liu, Jian-Ting Chen, Liang-Bi Xiang, Da-Peng Zhou.   

Abstract

Mesenchymal stem cells derived from adipose tissue have the capacity to differentiate into endodermal, mesoderm and ectodermal cell lineages in vitro, which are an ideal engraft in tissue-engineered repair. In this study, mouse adipose-derived stem cells (ADSCs) were isolated from subcutaneous fat. The markers of ADSCs, CD13, CD29, CD44, CD71, CD73, CD90, CD105, CD166, Nestin, GFAP and MAP-2 were detected by immunofluorescence assays. The ADSCs were cultured in cocktail factors (including ATRA, GGF-2, bFGF, PDGF and forskolin) for neurogenic differentiation. The neurogenic cells markers, Nestin, GFAP and MAP-2 were analyzed using immunofluorescence and real-time PCR after dramatic changes in morphology. Neurogenic cells from ADSCs were autologous transplanted into the mouse of spinal cord injury for observation neurogenic cells colonization in spinal cord. The result demonstrated that the mouse ADSCs were positive for the CD13, CD29, CD44, CD71, CD73, CD90, CD105 and CD166 but negative for neurogenic cell markers, MAP-2, GFAP and Nestin. After neurogenic differentiation, the neurogenic cells were positive for neurogenic cell special markers, gene expression level showed a time-lapse increase, and the cells were successful colonized into spinal cord. In conclusion, our research shows that a population of neuronal cells can be specifically generated from ADSCs and that induced cells may allow for participation in tissue-repair.

Entities:  

Mesh:

Year:  2014        PMID: 25330756     DOI: 10.1007/s10561-014-9476-3

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  6 in total

1.  Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.

Authors:  Junseok W Hur; Tai-Hyoung Cho; Dong-Hyuk Park; Jang-Bo Lee; Jung-Yul Park; Yong-Gu Chung
Journal:  J Spinal Cord Med       Date:  2015-07-24       Impact factor: 1.985

2.  Mouse Neural Stem Cell Differentiation and Human Adipose Mesenchymal Stem Cell Transdifferentiation Into Neuron- and Oligodendrocyte-like Cells With Myelination Potential.

Authors:  Anderson K Santos; Katia N Gomes; Ricardo C Parreira; Sérgio Scalzo; Mauro C X Pinto; Helton C Santiago; Alexander Birbrair; Ulrich Sack; Henning Ulrich; Rodrigo R Resende
Journal:  Stem Cell Rev Rep       Date:  2021-11-15       Impact factor: 5.739

Review 3.  Progress in Stem Cell Therapy for Spinal Cord Injury.

Authors:  Liansheng Gao; Yucong Peng; Weilin Xu; Pingyou He; Tao Li; Xiaoyang Lu; Gao Chen
Journal:  Stem Cells Int       Date:  2020-11-05       Impact factor: 5.443

4.  Transcriptome analysis and functional identification of adipose-derived mesenchymal stem cells in secondary lymphedema.

Authors:  Qinqin Xiang; Fen Xu; Yunzhu Li; Xuanyu Liu; Qianlong Chen; Jiuzuo Huang; Nanze Yu; Ziyi Zeng; Meng Yuan; Qixu Zhang; Xiao Long; Zhou Zhou
Journal:  Gland Surg       Date:  2020-04

5.  Enhanced renoprotective effect of HIF-1α modified human adipose-derived stem cells on cisplatin-induced acute kidney injury in vivo.

Authors:  Wei-Wei Wang; Ze-Zheng Li; Wei Wang; Yan Jiang; Jin Cheng; Shi Lu; Jin-Yuan Zhang
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

6.  MicroRNA Expression Profile of Neural Progenitor-Like Cells Derived from Rat Bone Marrow Mesenchymal Stem Cells under the Influence of IGF-1, bFGF and EGF.

Authors:  Tee Jong Huat; Amir Ali Khan; Jafri Malin Abdullah; Fauziah Mohamad Idris; Hasnan Jaafar
Journal:  Int J Mol Sci       Date:  2015-04-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.